Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 176

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Attribution of 12 High-Risk Human Papillomavirus Genotypes to Infection and Cervical Disease

Open access
Joura, Elmar A., Ault, Kevin A., Bosch, F. Xavier, Brown, Darron, Cuzick, Jack, Ferris, Daron, Garland, Suzanne M., Giuliano, Anna R., Hernandez-Avila, Mauricio, Huh, Warner, Iversen, Ole-Erik, Kjaer, Susanne K., Luna, Joaquin, Miller, Dianne, Monsonego, Joseph, Munoz, Nubia, Myers, Evan, Paavonen, Jorma, Pitisuttithum, Punnee, Steben, Marc, Wheeler, Cosette M., Perez, Gonzalo, Saah, Alfred, Luxembourg, Alain, Sings, Heather L., Velicer, Christine · 2014 · Cancer Epidemiology, Biomarkers & Prevention

Abstract

Background: We estimated the prevalence and incidence of 14 human papillomavirus (HPV) types (6/11/16/18/31/33/35/39/45/51/52/56/58/59) in cervicovaginal swabs, and the attribution of these HPV types in cervical intraepithelial neoplasia (CIN), and adenocarcinoma in situ (AIS), using predefined algorithms that adjusted for multiple-type infected lesions. Methods: A total of 10,656 women ages 15 to 26 years and 1,858 women ages 24 to 45 years were enrolled in the placebo arms of one of three clinical trials of a quadrivalent HPV vaccine. We estimated the cumulative incidence of persistent infection and the proportion of CIN/AIS attributable to individual carcinogenic HPV genotypes, as well as the proportion of CIN/AIS lesions potentially preventable by a prophylactic 9-valent HPV6/11/16/18/31/33/45/52/58 vaccine. Results: The cumulative incidence of persistent infection with ≥1 of the seven high-risk types included in the 9-valent vaccine was 29%, 12%, and 6% for women ages 15 to 26, 24 to 34, and 35 to 45 years, respectively. A total of 2,507 lesions were diagnosed as CIN or AIS by an expert pathology panel. After adjusting for multiple-type infected lesions, among women ages 15 to 45 years, these seven high-risk types were attributed to 43% to 55% of CIN1, 70% to 78% of CIN2, 85% to 91% of CIN3, and 95% to 100% of AIS lesions, respectively. The other tested types (HPV35/39/51/56/59) were attributed to 23% to 30% of CIN1, 7% to 14% of CIN2, 3% to 4% of CIN3, and 0% of AIS lesions, respectively. Conclusions: Approximately 85% or more of CIN3/AIS, >70% CIN2, and approximately 50% of CIN1 lesions worldwide are attributed to HPV6/11/16/18/31/33/45/52/58. Impact: If 9-valent HPV vaccination programs are effectively implemented, the majority of CIN2 and CIN3 lesions worldwide could be prevented, in addition to approximately one-half of CIN1. Cancer Epidemiol Biomarkers Prev; 23(10); 1997–2008. ©2014 AACR.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1158/1055-9965.epi-14-0410

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Cited by

See all 176

Metadata

Authors
Joura, E. A., Ault, K. A., Bosch, F. X., Brown, D., Cuzick, J., Ferris, D., Garland, S. M., Giuliano, A. R., Hernandez-Avila, M., Huh, W., Iversen, O.-E., Kjaer, S. K., Luna, J., Miller, D., Monsonego, J., Munoz, N., Myers, E., Paavonen, J., Pitisuttithum, P., Steben, M., Wheeler, C. M., Perez, G., Saah, A., Luxembourg, A., Sings, H. L., & Velicer, C.
Venue
Cancer Epidemiology, Biomarkers & Prevention
Published
2014-09-30
Volume
23
Issue
10
Pages
1997-2008
ISSN
  • 1055-9965 (ISSN-L)
  • 1538-7755
OpenAlex
W2165722018
Cited by
176
References
2
FWCI
15.73
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Attribution of 12 High-Risk Human Papillomavirus Genotypes to Infection and Cervical Disease. https://app.cochat.ai/papers/10.1158/1055-9965.epi-14-0410
The paper
Joura, E. A., Ault, K. A., Bosch, F. X., Brown, D., Cuzick, J., Ferris, D., Garland, S. M., Giuliano, A. R., Hernandez-Avila, M., Huh, W., Iversen, O.-E., Kjaer, S. K., Luna, J., Miller, D., Monsonego, J., Munoz, N., Myers, E., Paavonen, J., Pitisuttithum, P., . . . Velicer, C. (2014). Attribution of 12 High-Risk Human Papillomavirus Genotypes to Infection and Cervical Disease. Cancer Epidemiology, Biomarkers & Prevention. https://doi.org/10.1158/1055-9965.epi-14-0410

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.